Table of Contents
November 2019 Supplement
Experts address the challenges of TBAD and share their perspectives on the first FDA-approved endovascular system designed specifically for managing type B aortic dissection.
Sponsored by Cook Medical
In This Supplement
Considerations for Short-and Long-Term Goals in TBAD Treatment
The evidence to guide type B aortic dissection decisions and the aims of repair in acute, subacute, and chronic phases, as well as complicated and uncomplicated cases.
By Athanasios Katsargyris, MD; Pablo Marques de Marino, MD; Balazs Botos, MD; and Eric Verhoeven, MD, PhD
Controversies in Dissection Repair: Addressing Paraplegia
A review of this devastating complication including incidence rates after TEVAR for TBAD and the roles of left subclavian artery revascularization, aortic coverage, and cerebrospinal fluid drainage.
By Keagan Werner-Gibbings, MS, FRACS, and Bijan Modarai, PhD, FRCS